# ZDAI (DirectBooking Technology Co., Ltd.) - SEC EDGAR Financial Statements

> DirectBooking Technology Co., Ltd. reported $8.94M in revenue and a net loss of $13.29M for the fiscal year ended March 31, 2026 (down 53.6% year over year), with a -21.5% gross margin and a -153.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/ZDAI
- Markdown: https://convexityos.com/fundamentals/ZDAI.md
- SEC CIK: 0001966678
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001966678&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $8.94M | -53.6% YoY |
| Operating Income | FY 2026 | -$13.73M | -153.7% margin |
| Net Income | FY 2026 | -$13.29M | -148.8% net margin |
| Diluted EPS | FY 2026 | -$4.13 | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $130K | Total debt: $2.62M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $8.94M | $19.28M | $13.46M | $11.14M | $10.48M |
| Cost of Revenue | $10.86M | $17.60M | $10.70M | $8.97M | $7.52M |
| **Gross Profit** | -$1.92M | $1.68M | $2.77M | $2.18M | $2.96M |
| Total Operating Expenses | -- | -- | -- | -$769 | -- |
| **Operating Income** | -$13.73M | -$7.17M | $1.43M | $989K | $2.27M |
| **EBITDA** | -$13.60M | -$7.02M | $1.59M | $1.13M | -- |
| Interest Expense | $183K | $224K | $211K | $191K | $116K |
| Income Before Tax | -$13.56M | -$7.10M | $1.34M | $1.39M | $2.35M |
| Income Tax Expense | -$268K | -$119K | $247K | $220K | $358K |
| **Net Income** | -$13.29M | -$6.98M | $1.09M | $1.17M | $1.99M |
| Basic EPS | -$4.13 | -$4.52 | $0.78 | $0.80 | $1.44 |
| **Diluted EPS** | -$4.13 | -$4.52 | $0.78 | $0.80 | $1.44 |
| Basic Shares Outstanding | 3.2M | 1.5M | 1.4M | 1.4M | 1.4M |
| Diluted Shares Outstanding | 3.2M | 1.5M | 1.4M | 1.4M | 1.4M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $130K | $456K | $489K | $240K |
| **Cash & Short-Term Investments** | $130K | $456K | $489K | $240K |
| Accounts Receivable, Net | $2.88M | $6.79M | $4.91M | $3.90M |
| **Total Current Assets** | $16.93M | $10.88M | $7.77M | $6.85M |
| Property, Plant & Equipment, Net | $36K | $167K | $316K | $472K |
| **Total Non-Current Assets** | $2.46M | $4.83M | $5.60M | $4.81M |
| **Total Assets** | $19.39M | $15.70M | $13.37M | $11.66M |
| Accounts Payable | $1.05M | $760K | $2.04M | $2.63M |
| Deferred Revenue (Current) | -- | -- | $837K | $103K |
| **Total Current Liabilities** | $4.34M | $4.10M | $5.52M | $5.27M |
| Long-Term Debt | $852K | $951K | $1.04M | $1.08M |
| **Total Non-Current Liabilities** | $1.50M | $2.86M | $3.56M | $3.19M |
| **Total Liabilities** | $5.84M | $6.96M | $9.08M | $8.46M |
| **Total Debt (incl. Leases)** | $2.62M | $4.03M | $4.54M | $4.24M |
| Common Stock | -- | $1.3K | $1.1K | $1.1K |
| Retained Earnings | -$15.98M | -$2.69M | $4.29M | $3.20M |
| Accumulated Other Comp. Income | $127K | -- | -- | -- |
| **Total Stockholders' Equity** | $13.55M | $8.74M | $4.29M | $3.20M |
| Total Equity | $13.55M | $8.74M | $4.29M | $3.20M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $130K | $456K | $489K | $240K |
| **Cash & Short-Term Investments** | $130K | $456K | $489K | $240K |
| Accounts Receivable, Net | $2.88M | $6.79M | $4.91M | $3.90M |
| **Total Current Assets** | $16.93M | $10.88M | $7.77M | $6.85M |
| Property, Plant & Equipment, Net | $36K | $167K | $316K | $472K |
| **Total Non-Current Assets** | $2.46M | $4.83M | $5.60M | $4.81M |
| **Total Assets** | $19.39M | $15.70M | $13.37M | $11.66M |
| Accounts Payable | $1.05M | $760K | $2.04M | $2.63M |
| Deferred Revenue (Current) | -- | -- | $837K | $103K |
| **Total Current Liabilities** | $4.34M | $4.10M | $5.52M | $5.27M |
| Long-Term Debt | $852K | $951K | $1.04M | $1.08M |
| **Total Non-Current Liabilities** | $1.50M | $2.86M | $3.56M | $3.19M |
| **Total Liabilities** | $5.84M | $6.96M | $9.08M | $8.46M |
| **Total Debt (incl. Leases)** | $2.62M | $4.03M | $4.54M | $4.24M |
| Common Stock | -- | $1.3K | $1.1K | $1.1K |
| Retained Earnings | -$15.98M | -$2.69M | $4.29M | $3.20M |
| Accumulated Other Comp. Income | $127K | -- | -- | -- |
| **Total Stockholders' Equity** | $13.55M | $8.74M | $4.29M | $3.20M |
| Total Equity | $13.55M | $8.74M | $4.29M | $3.20M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$13.29M | -$6.98M | $1.09M | $1.17M | $1.99M |
| Depreciation & Amortization | $130K | $149K | $156K | $137K | -- |
| Change in Receivables | $1.96M | -$2.59M | -$1.00M | -$2.53M | -$834K |
| Change in Payables | -$254K | -$1.21M | -$479K | $1.06M | $1.15M |
| **Operating Cash Flow** | -$1.29M | -$2.82M | $2.39M | $840K | $1.96M |
| Capital Expenditure | -- | -- | -- | -$46K | -$544K |
| **Free Cash Flow** | -- | -- | -- | $794K | $1.42M |
| **Investing Cash Flow** | -$12.24M | $747 | $21K | -$46K | -$544K |
| Common Stock Issued | -- | $5.28M | -- | -- | -- |
| **Financing Cash Flow** | $13.22M | $2.79M | -$2.17M | -$664K | -$1.38M |
| **Net Change in Cash** | -$312K | -$33K | $249K | $129K | $41K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -21.5% | 8.7% | 20.6% | 19.5% | 28.2% |
| **Operating Margin** | -153.7% | -37.2% | 10.6% | 8.9% | 21.6% |
| **Net Profit Margin** | -148.8% | -36.2% | 8.1% | 10.5% | 19.0% |
| Return on Equity (ROE) | -98.1% | -79.9% | 25.4% | 36.5% | -- |
| Return on Assets (ROA) | -68.6% | -44.5% | 8.2% | 10.0% | -- |
| Current Ratio | 3.90x | 2.65x | 1.41x | 1.30x | -- |
| Quick Ratio | 0.69x | 1.77x | 0.98x | 0.79x | -- |
| Debt to Equity | 0.19x | 0.46x | 1.06x | 1.33x | -- |
| **Revenue Growth (YoY)** | -53.6% | +43.2% | +20.8% | +6.3% | -- |
| Gross Profit Growth (YoY) | -214.4% | -39.3% | +27.1% | -26.4% | -- |
| Operating Income Growth (YoY) | -- | -600.4% | +44.8% | -56.3% | -- |
| **Net Income Growth (YoY)** | -- | -739.7% | -6.5% | -41.4% | -- |
| EPS Growth (YoY) | -- | -679.5% | -2.5% | -44.4% | -- |
| Operating Cash Flow Growth (YoY) | -- | -217.8% | +185.0% | -57.2% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -44.1% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
